Compound Detail
CHEMBL3647303
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3647303 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WSWPDLXVTSTZJL-FLFQWRMESA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
437.0
MW (Da)
5.07
ALogP
5
HBA
0
HBD
52.8
PSA (Ų)
0.64
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 2 meas. best 8.28
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cannabinoid receptor 2 CHEMBL2470 | Ki | 8.28 | 8.28 | 5.2 | 1 |
| Cannabinoid receptor 2 CHEMBL253 | Ki | 8.05 | 8.05 | 9.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Cannabinoid receptor 2 | Ki | = | 5.2 | nM | 8.28 | Radioligand Binding Assays: The CB1 and CB2 radioligand binding assays described... | - |
| Cannabinoid receptor 2 | Ki | = | 9.0 | nM | 8.05 | Radioligand Binding Assays: The CB1 and CB2 radioligand binding assays described... | - |
Data from ChEMBL 36 via Core Engine